Dnmt3a is an epigenetic mediator of adipose insulin resistance.

Elife
Authors
Keywords
Abstract

Insulin resistance results from an intricate interaction between genetic make-up and environment, and thus may be orchestrated by epigenetic mechanisms like DNA methylation. Here, we demonstrate that DNA methyltransferase 3a (Dnmt3a) is both necessary and sufficient to mediate insulin resistance in cultured mouse and human adipocytes. Furthermore, adipose-specific Dnmt3a knock-out mice are protected from diet-induced insulin resistance and glucose intolerance without accompanying changes in adiposity. Unbiased gene profiling studies revealed as a key negatively regulated Dnmt3a target gene in adipocytes with concordant changes in DNA methylation at the promoter region. Consistent with this, Fgf21 can rescue Dnmt3a-mediated insulin resistance, and DNA methylation at the locus was elevated in human subjects with diabetes and correlated negatively with expression of in human adipose tissue. Taken together, our data demonstrate that adipose Dnmt3a is a novel epigenetic mediator of insulin resistance in vitro and in vivo.

Year of Publication
2017
Journal
Elife
Volume
6
Date Published
2017 11 01
ISSN
2050-084X
DOI
10.7554/eLife.30766
PubMed ID
29091029
PubMed Central ID
PMC5730374
Links
Grant list
R01 DK085171 / DK / NIDDK NIH HHS / United States
K08 DK097303 / DK / NIDDK NIH HHS / United States
R01 DK102173 / DK / NIDDK NIH HHS / United States
R01 DK113669 / DK / NIDDK NIH HHS / United States
R01 DK102170 / DK / NIDDK NIH HHS / United States